DISEASE AREAS

  • Oncology

    Advance your oncology research and drug development with us. We use cutting-edge technology to create mouse models including humanized models, immunodeficient models and spontaneous tumor models that better reflect human conditions, making them ideal for testing your agents and immuno-oncology research
Oncology Resources
We have an extensive collection of genetically engineered mice in oncology research and a variety of professional tests for preclinical study. Our comprehensive oncology platform will facilitate your drug development and cancer research.
  • Early Discovery
  • Pharmacodynamic Studies
  • Pharmacokinetics And Drug Metabolism
  • Saftey Evaluation
  • Knockout & Conditional Knockout Mouse Models
    Knockout & Conditional Knockout Mouse Models
    Our ambitious Knockout All Project (KOAP) aims to generate Knockout (KO) and Conditional Knockout (cKO) mouse strains for all ~23,000 protein coding genes in the mouse genome. Nearly 10,000+ genes have been successfully targeted thus far, providing Knockout Mouse Models and Conditional Knockout Mouse Models for a wide array of research fields.
  • Spontaneous Tumor Mouse Models/Cell Lines
    Spontaneous Tumor Mouse Models/Cell Lines
    Immune System Reconstructed Mouse Models
    Immune System Reconstructed Mouse Models
    CDX/PDX Mouse Models
    CDX/PDX Mouse Models
    Immunodeficient Mice (NCG)
    Immunodeficient Mice (NCG)
    Target Humanized Mice
    Target Humanized Mice
    Available Cell Lines
    Available Cell Lines
    Biological Analysis
    Biological Analysis
    In vivo Druggability Evaluation
    In vivo Druggability Evaluation
    In vitro Druggability Evaluation
    In vitro Druggability Evaluation
    We have an extensive collection of genetically engineered mice in oncology research and a variety of professional tests for preclinical study. Our comprehensive oncology platform will facilitate your drug development and cancer research.
  • PK/PD Analysis
    PK/PD Analysis
    We have an extensive collection of genetically engineered mice for use in oncology research as well as a preclinical study platform.
    Spontaneous Tumor Mouse Models/Cell lines
    Spontaneous Tumor Mouse Models/Cell lines
    Immune System Reconstructed Mouse Models
    Immune System Reconstructed Mouse Models
    CDX/PDX Mouse Models
    CDX/PDX Mouse Models
    Immunodeficient Mice (NCG)
    Immunodeficient Mice (NCG)
    Target Humanized Mice
    Target Humanized Mice
    Available Cell Lines
    Available Cell Lines
  • Immunodeficient Mice(NCG)
    Immunodeficient Mice(NCG)
    Target Humanized Mice
    Target Humanized Mice
    Non-GLP Safety Evaluation
    Non-GLP Safety Evaluation
    we have an extensive collection of genetically engineered mice in oncology research and a variety of professional tests for preclinical study. Our comprehensive oncology platform will facilitate your drug development and cancer research.
Cell & Gene therapy
Antibody drug
ADC drug
SiRNA drug
GemPharmatech and Charles River Laboratories Sign to Distribute Next Generation NCG Portfolio

GemPharmatech and Charles River Laboratories Sign to Distribute Next Generation NCG Portfolio

Moving from Discovery to Clinic with Genetically Engineered Mouse Models

Moving from Discovery to Clinic with Genetically Engineered Mouse Models

GemPharmatech and Charles River Laboratories Sign to Distribute Next Generation NCG Portfolio

GemPharmatech and Charles River Laboratories Sign to Distribute Next Generation NCG Portfolio

Moving from Discovery to Clinic with Genetically Engineered Mouse Models

Moving from Discovery to Clinic with Genetically Engineered Mouse Models

Moving from Discovery to Clinic with Genetically Engineered Mouse Models

Moving from Discovery to Clinic with Genetically Engineered Mouse Models

GemPharmatech and Charles River Laboratories Sign to Distribute Next Generation NCG Portfolio

GemPharmatech and Charles River Laboratories Sign to Distribute Next Generation NCG Portfolio

Moving from Discovery to Clinic with Genetically Engineered Mouse Models

Moving from Discovery to Clinic with Genetically Engineered Mouse Models

GemPharmatech and Charles River Laboratories Sign to Distribute Next Generation NCG Portfolio

GemPharmatech and Charles River Laboratories Sign to Distribute Next Generation NCG Portfolio

Moving from Discovery to Clinic with Genetically Engineered Mouse Models

Moving from Discovery to Clinic with Genetically Engineered Mouse Models

Moving from Discovery to Clinic with Genetically Engineered Mouse Models

Moving from Discovery to Clinic with Genetically Engineered Mouse Models

GemPharmatech and Charles River Laboratories Sign to Distribute Next Generation NCG Portfolio

GemPharmatech and Charles River Laboratories Sign to Distribute Next Generation NCG Portfolio

Moving from Discovery to Clinic with Genetically Engineered Mouse Models

Moving from Discovery to Clinic with Genetically Engineered Mouse Models

GemPharmatech and Charles River Laboratories Sign to Distribute Next Generation NCG Portfolio

GemPharmatech and Charles River Laboratories Sign to Distribute Next Generation NCG Portfolio

Moving from Discovery to Clinic with Genetically Engineered Mouse Models

Moving from Discovery to Clinic with Genetically Engineered Mouse Models

Moving from Discovery to Clinic with Genetically Engineered Mouse Models

Moving from Discovery to Clinic with Genetically Engineered Mouse Models

GemPharmatech and Charles River Laboratories Sign to Distribute Next Generation NCG Portfolio

GemPharmatech and Charles River Laboratories Sign to Distribute Next Generation NCG Portfolio

Moving from Discovery to Clinic with Genetically Engineered Mouse Models

Moving from Discovery to Clinic with Genetically Engineered Mouse Models

GemPharmatech and Charles River Laboratories Sign to Distribute Next Generation NCG Portfolio

GemPharmatech and Charles River Laboratories Sign to Distribute Next Generation NCG Portfolio

Moving from Discovery to Clinic with Genetically Engineered Mouse Models

Moving from Discovery to Clinic with Genetically Engineered Mouse Models

Moving from Discovery to Clinic with Genetically Engineered Mouse Models

Moving from Discovery to Clinic with Genetically Engineered Mouse Models

Webinar
Poster
Articles
Mouse Models with a Chromosome Derived from Wild Mice

Mouse Models with a Chromosome Derived from Wild Mice

Animal Models for Neurodegenerative Diseases: An Introduction to AD and PD Mouse Models

Animal Models for Neurodegenerative Diseases: An Introduction to AD and PD Mouse Models

KPC Mouse Model and Cell Line for Pancreatic Cancer Therapy Research

KPC Mouse Model and Cell Line for Pancreatic Cancer Therapy Research

The Challenges and Strategies of NK Cell Related IO Therapy in Preclinical Drug Evaluation

The Challenges and Strategies of NK Cell Related IO Therapy in Preclinical Drug Evaluation

Preclinical Evaluation of CAR T Immunotherapies Using Novel Animal Models

Preclinical Evaluation of CAR T Immunotherapies Using Novel Animal Models

CONTENT HUB
Humanized Mice Model for Efficacy and Toxicity Evaluation of Drugs Targeting CD47-SIRPα-PD1-PD-L1 Axes

Humanized Mice Model for Efficacy and Toxicity Evaluation of Drugs Targeting CD47-SIRPα-PD1-PD-L1 Axes

Humanized CD3EDG Mice: An Ideal Model to Study the Efficacy of CD3-Bispecific Antibodies

Humanized CD3EDG Mice: An Ideal Model to Study the Efficacy of CD3-Bispecific Antibodies

CD137 Humanized Mice for Preclinical Efficacy Evaluation of anti-CD137 Therapeutic Antibodies

CD137 Humanized Mice for Preclinical Efficacy Evaluation of anti-CD137 Therapeutic Antibodies

CONTENT HUB
CD34+ Humanized huHSC-NCG Mice Engrafted with Hematological Malignancies Models for Preclinical Study of Anti-Human CD19 Therapeutic Antibodies

CD34+ Humanized huHSC-NCG Mice Engrafted with Hematological Malignancies Models for Preclinical Study of Anti-Human CD19 Therapeutic Antibodies

CD137 Humanized Mice for Preclinical Efficacy Evaluation of anti-CD137 Therapeutic Antibodies

CD137 Humanized Mice for Preclinical Efficacy Evaluation of anti-CD137 Therapeutic Antibodies

NCG-X: A Novel Mouse Model for Preclinical Studies Evaluation Human Erythroid Reconstitution

NCG-X: A Novel Mouse Model for Preclinical Studies Evaluation Human Erythroid Reconstitution

CONTENT HUB